Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy
Iurin, O.G.
Terapevticheskii Arkhiv 79(11): 67-69
2007
ISSN/ISBN: 0040-3660 PMID: 18219979 Document Number: 613030
Document emailed within 1 workday
Related Documents
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194Sempa, J.; Ssennono, M.; Kuznik, A.; Lamorde, M.; Sowinski, S.; Semeere, A.; Hermans, S.; Castelnuovo, B.; Manabe, Y.C. 2012: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda Bmc Public Health 12: 736
Taniguchi, H.; Izumi, S. 2007: A case of tuberculosis showing immune reconstitution syndrome after the initiation of antiretroviral therapy for HIV infection Kekkaku: 82(1): 27-31
Humphreys, E.H.; Chang, L.W.; Harris, J. 2010: Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database of Systematic Reviews 6: Cd006517
Newman, H.; Breunig, L.; van Zyl, G.; Stich, A.; Preiser, W. 2014: A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 387-391
MacPherson, P.; Lalloo, D.G.; Webb, E.L.; Maheswaran, H.; Choko, A.T.; Makombe, S.D.; Butterworth, A.E.; van Oosterhout, J.J.; Desmond, N.; Thindwa, D.; Squire, S.B.; Hayes, R.J.; Corbett, E.L. 2014: Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial JAMA 312(4): 372-379
Kumarasamy, N.; Chaguturu, S.; Mayer, K.H.; Solomon, S.; Yepthomi, H.Tokugha.; Balakrishnan, P.; Flanigan, T.P. 2004: Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India Journal of Acquired Immune Deficiency Syndromes 37(5): 1574-1576
Satti, H.; McLaughlin, M.M.; Hedt-Gauthier, B.; Atwood, S.S.; Omotayo, D.B.; Ntlamelle, L.; Seung, K.J. 2012: Outcomes of multidrug-resistant tuberculosis treatment with early initiation of antiretroviral therapy for HIV co-infected patients in Lesotho Plos one 7(10): E46943
Tesfaye, Z.; Enawgaw, B. 2014: Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study Bmc Research Notes 7: 745
Diabaté, S.; Chamberland, A.; Zannou, D.M.; Geraldo, N.; Azon-Kouanou, Aèle.; Massinga-Loembé, Mérite.; Ahomadégbé, C.; Labbé, A-Claude.; Tremblay, Cécile.; Alary, M. 2013: Sexual behaviour after antiretroviral therapy initiation in female sex workers and HIV-positive patients from the general population, Cotonou, Benin Aids Care 25(11): 1426-1432
Agbaji, O.O.; Abah, I.O.; Falang, K.D.; Ebonyi, A.O.; Musa, J.; Ugoagwu, P.; Agaba, P.A.; Sagay, A.S.; Jolayemi, T.; Okonkwo, P.; Idoko, J.A.; Kanki, P.J. 2015: Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria Current HIV Research 13(3): 184-192
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sharma, S.; Khadga, P.; Dhungana, G.P.; Chitrakar, U. 2013: Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal Kathmandu University Medical Journal 11(41): 50-53
Vijayan, T.; Semitala, F.C.; Matsiko, N.; Elyanu, P.; Namusobya, J.; Havlir, D.V.; Kamya, M.; Geng, E.H. 2013: Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57(12): 1766-1772
Muhamadi, L.; Tumwesigye, N.M.; Kadobera, D.; Marrone, G.; Wabwire-Mangen, F.; Pariyo, G.; Peterson, S.; Ekström, A.M. 2011: Lack of pre-antiretroviral care and competition from traditional healers, crucial risk factors for very late initiation of antiretroviral therapy for HIV--a case-control study from eastern Uganda Pan African Medical Journal 8: 40
Onoya, D.; Hirasen, K.; van den Berg, L.; Miot, J.; Long, L.C.; Fox, M.P. 2018: Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa Drug Safety 41(12): 1343-1353
Chawana, T.D.; Reid, A.; Bwakura, T.; Gavi, S.; Nhachi, C.F.B. 2014: Factors influencing treatment failure in HIV positive adult patients on first line antiretroviral therapy Central African Journal of Medicine 60(5-8): 29-36
Khan, S.; Das, M.; Andries, A.; Deshpande, A.; Mansoor, H.; Saranchuk, P.; Isaakidis, P. 2014: Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India Global Health Action 7: 24861
Teasdale, C.A.; Wang, C.; Francois, U.; Ndahimana, J.d.ʼA.; Vincent, M.; Sahabo, R.; El-Sadr, W.M.; Abrams, E.J. 2015: Time to initiation of antiretroviral therapy among patients who Are ART eligible in Rwanda: improvement over time Journal of Acquired Immune Deficiency Syndromes 68(3): 314-321